<DOC>
	<DOCNO>NCT02044874</DOCNO>
	<brief_summary>In smoker motivate stop smoking , treatment lorcaserin compare placebo provide great abstinence measure last 4 week treatment ( Weeks 9-12 )</brief_summary>
	<brief_title>A Study Evaluate Effect Lorcaserin Hydrochloride Smoking Cessation</brief_title>
	<detailed_description />
	<criteria>1 . Males female age 1865 year , inclusive 2 . ≥10 cigarette per day period abstinence longer 3 month past year motivate quit smoking 3 . Able give sign informed consent 4 . Eligible female patient : 1. nonpregnant 2. nonlactating 3. agree use acceptable method effective contraception study 5 . Eligible male patient agree use contraception sexually active female partner use acceptable method birth control 6 . Body weight ≥50 kg ( 110 pound ) , inclusive 7 . Considered stable health opinion investigator Patients meet follow criterion exclude study . 1 . Prior current use lorcaserin HCl 2 . Prior participation study nicotine vaccination 3 . Use therapy smoke cessation allow within 3 month screen study exit 4 . Use tobacco product cigarettes 5 . Prior use fenfluramine dexfenfluramine 6 . Serious unstable medical condition clinically significant new illness within 6 month prior screen 7 . Previous participation clinical study within 6 week prior screen visit 8 . History severe allergy , severe drug excipient allergy hypersensitivity 9 . History significant cardiovascular condition 10 . History significant medical condition 11 . Significant risk suicide 12 . Anticipated use agent associate valvulopathy and/or pulmonary hypertension 13 . Positive test result human immunodeficiency virus ( HIV ) , hepatitis B , hepatitis C 14 . Recent history alcohol drug/solvent abuse 15 . Concurrent participation study one member household 16 . Not suitable participate study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>